CVRx Inc Q3 2024 Earnings Revenue Hits 13.4M, EPS at -0.57, Surpassing Estimates
| CVRX Stock | USD 13.64 0.06 0.44% |
Slightly above 52% of CVRx's investors are presently thinking to get in. The analysis of overall sentiment of trading CVRx Inc stock suggests that some investors are interested at this time. CVRx's investing sentiment can be driven by a variety of factors including economic data, CVRx's earnings reports, geopolitical events, and overall market trends.
CVRx |
Revenue Achieved 13.4 million for Q3 2024, surpassing analyst estimates of 13.21 million and marking a 27 percent increase year-over-year.Net Loss Reported a net
Read at gurufocus.com
 |
CVRx Fundamental Analysis
We analyze CVRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
CVRx is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
CVRx Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CVRx stock to make a market-neutral strategy. Peer analysis of CVRx could also be used in its relative valuation, which is a method of valuing CVRx by comparing valuation metrics with similar companies.
Peers
CVRx Related Equities
| AXDX | Accelerate Diagnostics | 7.14 | ||||
| KIDS | Orthopediatrics Corp | 2.10 | ||||
| ELMD | Electromed | 1.96 | ||||
| LIVN | LivaNova PLC | 1.33 | ||||
| OFIX | Orthofix Medical | 0.52 | ||||
| LUNG | Pulmonx Corp | 0.46 | ||||
| NPCE | Neuropace | 0.09 | ||||
| ANIK | Anika Therapeutics | 0.12 | ||||
| SRDX | SurModics | 0.40 | ||||
| AORT | Artivion | 0.71 | ||||
| AXGN | Axogen | 1.77 | ||||
| SGHT | Sight Sciences | 2.51 |
Additional Tools for CVRx Stock Analysis
When running CVRx's price analysis, check to measure CVRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVRx is operating at the current time. Most of CVRx's value examination focuses on studying past and present price action to predict the probability of CVRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVRx's price. Additionally, you may evaluate how the addition of CVRx to your portfolios can decrease your overall portfolio volatility.